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Background. Controversial findings are reported on hospital outcome in cognitively impaired patients. The aim of 
this study was to explore mortality risk according to cognitive status during hospitalization and after 3 months in elderly 
patients.
Methods. Sixty-six internal medicine and geriatric wards in Italy participated in the “Registry Politerapie SIMI 
(REPOSI)” during 2010. Of the 1,380 in-patients, aged 65 and older enrolled, 1,201 were included. Cognition was evalu-
ated with the Short Blessed Test (SBT). Logistic regression was used to evaluate the association of questionable and 
impaired cognition (according to SBT cutoff points) with mortality during hospitalization and at follow-up. Morbidity, 
function, and adverse events during hospitalization were covariates.
Results. Four hundred and twenty-one participants were classified as normal, 219 questionable, and 561 cognitively 
impaired. Forty-nine patients died during hospitalization and 70 during follow-up. Sixty-seven point three percent versus 
32.7% (p < .001) of patients who died during hospitalization and 54.3% versus 45.7% (p < .001) during follow-up had at 
least one adverse event. After multiadjustment, impaired cognition was associated with in-hospital mortality (odds ratio 
[OR] = 3.1; 95% confidence interval [CI] = 1.1–8.6) but not with mortality at follow-up. Increase severity of cognitive 
impairment was associated with higher odds of mortality (from 2.7 in those with moderate impairment to 4.2 in those 
with severe impairment). After stratification for adverse clinical events, impaired cognition resulted associated with mor-
tality only in patients having at least one event.
Conclusion. Elderly patients with cognitive impairment are more likely to die during hospitalization with a 
severity-dependent association. Adverse events may represent an important target of prevention due to their high associa-
tion with mortality and cognitive impairment.
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DUE to the well-known demographic and epidemiologi-cal transitions, an increasing number of old people will 
be hospitalized while suffering not only from the acute dis-
ease leading to admission but also due to several coexisting 
chronic diseases and syndromes, such as cognitive impair-
ment. Several studies have shown that patients with demen-
tia or cognitive impairment are likely to have such adverse 
outcomes as high risk of institutionalization after discharge 
(1,2), longer length of hospital stay (3), and functional status 
decline prior and after hospitalization (4,5). Moreover, a few 
studies showed that dementia is associated with long- and 
short-term mortality after hospital admission (6). Morrison 
and colleagues (7) found that the admission to hospital of a 
person with dementia and acute medical illness is a critical 
event associated with high 6-month mortality rates. Recently, 
Sampson and colleagues (8) showed that dementia is 
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associated with markedly high mortality during hospital stay, 
especially those patients with severe cognitive impairment. 
In the first wave of the Registry Politerapie SIMI (Italian 
Internal Medicine Society), REPOSI, held in 2008, we found 
that patients with a diagnosis of dementia were more likely 
to die during hospital stay compared with their cognitively 
intact pairs despite similar comorbidities (9). Finally, a fre-
quent event in patients with dementia, that is, the onset of 
delirium during hospital stay (10), has been found as a risk 
factor for both short- and long-term mortality (11,12). For this 
reason, the onset of delirium after admission was recorded as 
an adverse clinical event in this population sample.
The aim of this study was to explore if older persons admit-
ted to acute hospital wards with questionable or impaired 
cognition have a higher risk of in-hospital and 3-month mor-
tality compared with their cognitively intact peers, after con-
trolling for other key factors, including physical illnesses, 
functional disability, and adverse clinical events during hos-
pitalization. Data were obtained from the REPOSI during 
2010 in 66 internal medicine and geriatric wards in Italy.
Methods
Data Collection
This study was conducted between January 2010 and 
December 2010 in 66 hospitals wards located in different 
regions of Italy, all participating in the REPOSI, a collabo-
rative and independent joint effort of the Italian Society of 
Internal Medicine (SIMI) and the Mario Negri Institute of 
Pharmacological Research. The design of REPOSI was pre-
viously described in details (13). Briefly, the registry was 
designed with the purpose to create a network of internal 
medicine and geriatric wards in order to evaluate patients 
affected by multiple diseases and prescribed with poly-
therapy. The specific aims of REPOSI were as follows: to 
describe prevalence of co-occurring multiple diseases and 
treatments in hospitalized elderly patients; to correlate clini-
cal characteristics of the patients with type and number of 
diseases and treatments; and to evaluate the main clinical 
outcomes at hospital discharge and to compare drug pre-
scriptions at admission, discharge, and follow-up. All the 
patients admitted to the participating wards were con-
secutively recruited if they were aged 65  years and older. 
Participation was voluntary and an informed consent was 
signed by all patients. A sample of at least 20 patients con-
secutively admitted to each participating hospital during 
a period of 4 weeks, 3  months apart each from the other 
(one in February, one in June, one in September, and one 
in December 2010) was enrolled in the study. A standard-
ized web-based case report form was filled in by the attend-
ing physicians, including sociodemographic factors, clinical 
parameters, diagnoses, and medications prescribed at both 
hospital admission and discharge and clinical events dur-
ing hospitalization. Telephone follow-up was performed 
3  months after hospital discharge collecting data on mor-
tality. All the data recorded in the net were collected and 
checked by a central monitoring institution (the Mario Negri 
Institute for Pharmacological Research, Milan).
The study was approved by the Ethical Committee of 
the IRCCS Cà Granda Maggiore Policlinico Hospital 
Foundation, Milan.
Assessment of Cognitive Status
The Short Blessed Test (SBT) was performed 
within 2  days of hospital admission. SBT is a 6-item 
Orientation-Memory-Concentration-Test validated as a 
measure of cognitive impairment (14). Based on findings 
from the Memory and Aging Project (15), the following 
cutoff points were considered normal cognition (score of 
0–4), questionable impairment (score of 5–9), and impair-
ment consistent with dementia (score of 10–28). In the final 
analysis, impaired patients were also divided in those with 
moderate impairment (score of 10–19) and severe impair-
ment (score ≥ 20).
Assessment of Performance in Basic Activities 
of Daily Living
The Barthel Index is a scale used for the assessment 
of performance in basic activities of daily living (16) that 
considers 10 basic functions and yields a score of 0–100. 
A  higher score is associated with a greater likelihood of 
being able to live at home with a degree of independence 
following discharge from hospital. The Barthel Index was 
categorized according to four cutoff points, which are as 
follows: 75–100 as reference (no-mild disability), 50–74 
(moderate disability), 25–49 (severe disability), and 0–24 
(completely dependent).
Assessment of Diseases
Diseases examined in this study were diagnosed on the 
basis of physical examination, clinical history, and labo-
ratory and instrumental data collected by the attending 
physicians. The International Classification of Diseases—
Ninth Revision (17) was used for classifying diseases. 
The Cumulative Illness Rating Scale was adopted in order 
to evaluate the global health status of participants (18). 
Clinicians evaluate in each patient the disease and impair-
ment of major organ systems, which are rated from 1 (no 
impairment to that organ/system) to 5 (impairment is life 
threatening). A severity index and a comorbidity index can 
be derived. The comorbidity index is calculated according to 
the number of organ systems affected by a severity of at least 
3. In this study, the Cumulative Illness Rating Scale comor-
bidity index was used for descriptive purpose only but was 
not included in the multivariate models. Instead, single dis-
eases potentially related to death were included because they 
were thought to be more informative than the index alone.
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Adverse Clinical Events
Adverse clinical events were defined as any acute clini-
cal problem that newly occurred during hospitalization 
(and was not present at admission [19]). The participating 
centers were not provided with an encoded list of possible 
adverse events. The judgment was clinical and the final data 
on adverse events were checked by a senior physician from 
the central monitor group. The final list of adverse events 
in alphabetical order was the following: acute renal fail-
ure, acute pulmonary embolism, acute heart failure, acute 
coronary heart disease, acute respiratory failure, allergy, 
arrhythmias, bedsores, behavioral disturbances, delirium, 
electrolyte disorders, epilepsy, falls, fever, fractures, hem-
orrhagic events, hypertensive crisis, infections (intestinal, 
skin, bronchitis, sepsis, pancreatitis, urinary, herpes zoster), 
pneumonia, stroke, syncope, thrombosis, uncontrolled dia-
betes, and vertigo.
Mortality
Information on survival status of the patients was col-
lected during hospitalization and assessed 3 months after 
discharge by telephone interview to patients or relatives. 
Follow-up data were available for 900 participants out of 
the 1,380 enrolled (65%) and for 850 out of those included 
in this study (n = 1,201; 71%). In fact, the initial registry 
sample included 1,380 participants. For 32 of them, infor-
mation on survival status at discharge was missing, 120 
were transferred to other hospital units, and 27 had missing 
data on the SBT. Thus, 1,201 patients were included in this 
study.
Statistical Analysis
Sociodemographic and clinical characteristics of the sam-
ple according to cognitive status were described using uni-
variate analysis (mean or percentage). Ninety-five percent 
confidence intervals (CIs) were calculated for means and 
proportions. Logistic regression models were run to analyze 
the association between cognitive impairment and mortal-
ity during hospitalization and after 3-month follow-up. 
Covariates were dichotomized according to clinical judg-
ment or mean values. The adjustment included age (years, 
dichotomized 80+ vs <80 in order to highlight the effect 
of the oldest old), gender (males vs females), education 
(years of schooling), functional status (the Barthel Index 
was categorized according to four cutoff points as follows: 
75–100 as reference [no-mild disability], 50–74 [moderate 
disability], 25–49 [severe disability], and 0–24 [completely 
dependent]), adverse clinical events during hospitalization 
(1+ vs 0 events), and diseases potentially related to death 
(malignancy, cerebrovascular diseases, chronic obstructive 
pulmonary disease, heart failure, coronary heart disease, 
and chronic renal failure). In order to evaluate if the sever-
ity of cognitive impairment was associated with a different 
risk of death, the SBT scale score was further categorized 
according to four cutoff points; 0–4 (normal), 5–9 (ques-
tionable), 10–19 (moderate impairment), and 20+ (severe 
impairment). Finally, stratification was employed in order 
to evaluate a possible interaction between adverse clinical 
events and having questionable or impaired cognition ver-
sus being normal.
All the statistical calculations were performed with the 
software STATA 12th version (College Station, Texas, 
USA).
Results
Of the 1,201 patients included in this study, 48.3% were 
men. The mean age of the patients was 79 years. Thirty-four 
percent of them had at least one adverse clinical event during 
the hospital stay (ranging from 0 to 6 events). Concerning 
cognitive status, 421 patients were classified as normal, 
219 questionable, and 561 cognitively impaired according 
to SBT cutoff points. Forty-nine patients (4.0%) died 
during hospitalization and 70 (8.2%) during the 3-month 
follow-up. Patients who underwent or not the follow-up 
did not differ according to age (mean 78.8 vs 79.2 years, 
p = .277), gender (49.3 vs 49. 9% males, p = .827), SBT 
(mean 9.6 vs 10.2, p = .205), and adverse events (mean 1.5 
vs 1.6, p = .475). Patients without follow-up were slightly 
more functionally impaired (mean Barthel Index 71.4 vs 
79.5, p< .001). The main causes of in-hospital death were 
pneumonia or respiratory failure, cardiovascular diseases, 
and sepsis, whereas the main causes of 3-month mortality 
were pneumonia or respiratory failure, malignancy, and 
cardiovascular diseases. Sixty-seven point three percent 
versus 32.7%, p < .001, of patients who died during 
hospitalization and 54.3% versus 45.7%, p < .001, who died 
during follow-up had at least one adverse event compared 
with survivors.
Table  1 shows sociodemographic and clinical char-
acteristics in the whole patient sample and according to 
cognitive status. Patients with questionable or impaired 
cognition were more likely to be older, less educated, and 
more functionally impaired; a higher proportion of them 
had at least one adverse clinical event during hospital stay 
and died during hospitalization or follow-up (Table  1). 
They were also more likely to die because of pneumonia 
or respiratory failure and sepsis during hospitalization and 
because of pneumonia or respiratory failure, sepsis, malig-
nancy, and cardiovascular diseases at follow-up than those 
cognitively intact.
The most frequent adverse clinical events are described 
in Figure  1 according to cognitive status. They were uri-
nary infection, pneumonia, acute renal failure or electrolyte 
disorders, respiratory failure, delirium, and Clostridium dif-
ficile infection.
The crude effects of questionable and impaired cogni-
tion on in-hospital and 3-month mortality (being normal 
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cognition the reference group) were as follows: for ques-
tionable cognition OR = 2.3 (95% CI = 0.7–7.7) and OR 
= 2.1 (95% CI = 1.04–4.4) and for impaired cognition OR 
= 6.0 (95% CI = 2.3–15.4) and OR = 1.9 (95% CI = 1.07–
3.6), respectively. Due to the high correlation between the 
SBT score and the Barthel Index score (Pearson correlation: 
−0.526, p < .001), we also analysed the crude effects of 
functional impairment on in-hospital and 3-month mortal-
ity (being normal-mild disability, the reference group) that 
were as follows: for moderate impairment OR = 0.6 (95% 
CI = 0.1–2.6) and OR = 2.2 (95% CI = 1.0–4.9), for severe 
impairment OR = 3.0 (95% CI = 1.2–7.4) and OR = 4.7 
(95% CI = 2.1–10.4), and for complete disability OR = 5.6 
(95% CI = 2.7–11.3) and OR = 6.8 (95% CI = 3.4–13.6), 
respectively. Multivariate logistic regression models meant 
to identify whether there was an independent association 
between cognitive impairment and in-hospital (Model 1 and 
2) and 3-month mortality (Model 3 and 4). Model 1 and 3 
were adjusted only for age and gender, whereas Model 2 
and 4 also for education, functional status, adverse clini-
cal events, and diseases. Cognitively impaired patients were 
more likely to die during hospitalization, whereas question-
able impaired patients showed no association with in-hos-
pital mortality. On the other hand, both questionable and 
cognitively impaired patients did not show an independent 
effect on mortality at follow-up after multiadjustment com-
pared with those classified as cognitively normal. Adverse 
clinical events were also independently associated with in-
hospital and follow-up mortality (Table 2; Model 2 and 4). 
The other variables significantly associated with mortality 
were older age, male gender, and being affected by malig-
nancy and chronic renal failure (Table 2).
In order to better evaluate whether an increasing severity 
of cognitive impairment was associated with an increased 
risk of death, the SBT scale score was categorized accord-
ing to four cutoff points: 0–4 (normal, reference group), 
5–9 (questionable), 10–19 (moderate impairment), and 
20+ (severe impairment). After multiadjustment, the ORs 
for in-hospital mortality were as follows: for questionable 
impairment, OR = 2.2 and 95% CI = 0.66–7.71; for moder-
ate impairment, OR = 2.7 and 95% CI = 1.00–7.96; and for 
severe impairment, OR = 4.2 and 95% CI = 1.29–13.78. 
The association with 3-month mortality was not significant.
Finally, the models testing mortality were stratified 
according to adverse events. Being cognitively impaired 
was highly associated with mortality during hospital stay 
only in patients who had at least one adverse event during 
hospitalization (Table 3).
Table 1. Sociodemographic and Clinical Characteristics of the Whole Sample and By Cognitive Status
Characteristics All (N = 1201)
Cognitive Status
Normal (N = 421) Questionable (N = 219) Impaired (N = 561)
Age, y, M 79.1 (78.7–79.5) 76.5(75.8–77.2) 78.0 (77.1–79.0) 81.4 (80.8–82.0)
Males, % 48.3 (45.5–51.2) 53.2 (48.4–57.9) 52.9 (46.3–59.6) 42.9(38.8–47.0)
Education, y, M 7.1 (6.9–7.3) 8.3 (7.9–8.8) 7.6 (7.1–8.2) 5.9 (5.7–6.2)
At least one adverse hospital event, % 34.0 (31.3–36.7) 28.0 (23.7–32.3) 29.2 (23.1–35.2) 40.4 (36.3–44.5)
Barthel Index score, M 77.2 (75.4–78.9) 89.6 (87.7–91.6) 83.4 (80.3–86.5) 64.8 (61.9–67.7)
Cumulative Illness Rating Scale, comorbidity index, M 2.89 (2.80–2.99) 2.62 (2.46–2.78) 2.83 (2.58–3.07) 3.13 (2.98–3.28)
In-hospital mortality, % 4.0 (2.9–5.2) 1.1 (0.1–2.2) 2.7 (0.5–4.9) 6.7 (4.6–8.8)
Three-month mortality, % 8.2 (6.4–10.1) 5.1 (2.5–7.6) 10.4 (5.6–15.1) 9.7 (6.7–12.6)
Malignancy, % 16.4 (14.3–18.5) 19.7 (15.8–23.5) 16.8 (11.8–21.8) 13.7 (10.8–16.5)
HF, % 18.5 (16.3–20.7) 15.2 (11.7–18.6) 19.1 (13.9–24.4) 20.8 (17.4–24.2)
CHD, % 23.3 (20.9–25.7) 23.0 (19.0–27.0) 22.3 (16.8–27.9) 23.8 (20.3–27.4)
AF, % 23.1 (20.7–25.5) 21.1 (17.2–25.0) 22.8 (17.2–28.4) 24.7 (21.1–28.3)
COPD, % 24.1 (21.7–26.5) 24.2 (20.1–28.3) 26.0 (20.1–31.8) 23.3 (19.8–26.8)
CVD, % 20.5 (18.2–22.8) 15.6 (12.1–19.1) 17.3 (12.2–22.4) 25.4 (21.8–29.1)
CRF, % 16.3 (14.2–18.4) 15.4 (11.9–18.9) 15.0 (10.2–19.8) 17.4 (14.3–20.6)
Notes: Data are given as means or proportions (95% confidence intervals [CI]). AF = atrial fibrillation; CHD = coronary heart disease; COPD = chronic 
obstructive pulmonary disease; CRF = chronic renal failure; CVD = cerebrovascular disease; HF = heart failure; N = number.
Figure 1. Prevalence of most frequent adverse clinical events according to 
cognitive status (normal = Short Blessed Test [SBT] 0–4, questionable = SBT 
5–9, and impaired = SBT 10–28).
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Discussion
These findings obtained in the frame of the REPOSI 
registry confirmed previous results on the independent 
association between in-hospital mortality and cognitive 
impairment (9), and added novel information on patients 
with different severity of cognitive impairment and on mor-
tality at 3 months after discharge. The association between 
cognitive impairment and in-hospital mortality remained 
statistically significant after adjustment for several covari-
ates, including morbidity, functional status, and adverse 
clinical events, whereas the one with 3-month mortality was 
annulled by the inclusion in the models of functional sta-
tus. Moreover, increasing severity of cognitive impairment 
was associated with an increasing probability to die dur-
ing hospitalization. Adverse clinical events were especially 
frequent in patients with cognitive impairment and were 
independently associated with mortality both during hos-
pital stay and at follow-up. After stratification for adverse 
clinical events, impaired cognition resulted highly associ-
ated with in-hospital mortality only in patients having at 
least one event.
One of the major consequences of the ongoing 
demographic changes and population aging is the increase 
in the occurrence of mental diseases (20) that will result in 
an increasing number of patients with cognitive impairment 
being hospitalized in an acute care unit, such as geriatric 
Table 2. Odds Ratios (OR) and 95% Confidence Intervals (CI) for In-Hospital (Model 1 and 2) and 3-Month Mortality (Model 3 and 4)
In-Hospital Mortality Three-Month Mortality
Model 1 Model 2 Model 3 Model 4
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
SBT
 Normal R — R — R — R —
 Questionable 2.2 0.66–7.40 2.2 0.65–7.69 2.0 0.95–4.24 2.0 0.90–4.71
 Impaired 5.2 1.97–13.71 3.1 1.12–8.64 1.6 0.87–3.28 1.1 0.48–2.35
Barthel Index
 No-mild disability — — R — — — R —
 Moderate disability — — 0.5 0.11–2.34 — — 2.6 1.11–6.32
 Severe disability — — 2.5 1.01–6.40 — — 4.7 1.89–12.01
 Complete disability — — 5.4 2.53–11.71 — — 11.4 4.98–26.12
 Age, y (80+ vs <80) 2.6 1.31–5.32 1.6 0.78–3.47 2.8 1.61–5.06 3.1 1.60–6.04
 Male vs female 2.0 1.08–3.67 2.1 1.07–4.19 2.3 1.35–3.93 2.6 1.42–5.09
 Adverse events (1+ vs 0) — — 3.1 1.64–5.99 — — 1.7 1.01–3.11
 Malignancy — — 1.9 0.59–6.46 — — 6.2 3.36–11.49
 CRF — — 2.5 1.17–5.57 — — 1.9 1.02–3.67
Notes: Model 2 and 4 were adjusted also for education, CHD, AF, COPD, CVD, and HF, which are not reported in the table because not significant. AF = atrial 
fibrillation; CHD = coronary heart disease; COPD = chronic obstructive pulmonary disease; CRF = chronic renal failure; CVD = cerebrovascular disease; HF = 
heart failure; SBT = Short Blessed Test.
Table 3. Odds Ratio (OR) and 95% Confidence Intervals (CI) for In-Hospital and 3-Month Mortality After Stratification for the Presence of At 
Least One Adverse Clinical Event
At Least One Adverse Clinical Event No Adverse Clinical Event
In-hospital mortality Three-month mortality In-hospital mortality Three-month mortality
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
SBT
 Normal R — R — R — R —
 Questionable  8.8 0.94–82.84 2.7 0.76–9.88 0.59 0.09–3.63  1.5 0.51–4.95
 Impaired 13.2 1.68–104.24 1.5 0.48–4.88 0.60 0.14–2.48  0.7 0.24–2.49
Barthel Index
 No-mild disability R — R — R — R —
 Moderate disability  0.6 0.13–3.21 1.8 0.49–7.05 1* —  4.1 1.24–13.93
 Severe disability  1.7 0.54–5.73 3.0 0.81–11.23  6.2 1.24–31.18  8.0 2.06–31.29
 Complete disability  3.5 1.36–9.05 7.4 2.30–24.37 15.0 3.90–57.84 27.5 7.61–99.73
 Age, y (80+ vs <80)  1.2 0.50–3.12 4.5 1.66–12.62  3.6 0.93–14.51  2.2 0.85–6.01
 Male vs female  1.8 0.80–4.15 4.1 1.65–10.51  3.4 0.98–12.3  1.7 0.67–4.55
 Malignancy  1.2 0.23–6.74 7.5 3.07–18.45  3.5 0.55–22.47  8.3 3.07–22.79
 CRF  2.8 1.02–7.72 2.1 0.83–5.64  3.1 0.85–11.53  2.6 1.03–6.91
Notes: Models were adjusted also for education, CHD, AF, COPD, CVD, and HF, which are not reported in the table because not significant. AF = atrial 
fibrillation; CHD = coronary heart disease; COPD = chronic obstructive pulmonary disease; CRF = chronic renal failure; CVD = cerebrovascular disease; HF = 
heart failure.
*Predicts failure perfectly (no one in this group died during hospitalization).
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and internal medicine wards. Previous studies on the effect 
of dementia on hospital outcomes gave controversial 
results. Zekry and colleagues (1) investigated geriatric 
patients from acute and rehabilitation hospitals and found 
that dementia was not predictive of in-hospital death, but 
only of discharge to a nursing home. In an additional study 
from the same group, dementia was confirmed not to be 
predictive of short- or long-term mortality if comorbidities 
were included in the model (21). On the other hand, 
Dinkel and Lebok (22) compared hospital outcomes in 
German patients with and without dementia and found 
that in-patients with dementia had a twofold likelihood to 
die during hospitalization than those without dementia of 
the same age. These results were explained by a higher 
number of comorbid conditions in patients with dementia 
compared with those who were cognitively intact (22). 
A  greater load of comorbidity and geriatric syndromes 
was observed also in patients with dementia admitted to an 
Italian hospital, who showed a higher mortality risk than in 
their cognitively intact pairs (23). We found similar results 
regarding the association of dementia with mortality during 
acute hospitalization in the first wave of the REPOSI, but—
in that study—patients with dementia had a similar number 
of comorbid conditions than those without dementia (9). In 
this second wave of the registry, not only more information 
on possible confounders, such as functional status, was 
collected compared with the first wave, but also the severity 
of cognitive impairment was tested by using the SBT scale. 
Increasing severity of cognitive impairment resulted in an 
increasing probability to die during hospitalization, ranging 
from an OR of 2.7 in those with moderate impairment to 4.2 
in those with severe impairment.
The reasons why patients affected by cognitive impair-
ment may be at high risk to die during acute diseases are still 
not unclear. Some studies have shown that the acute care of 
patients affected by dementia tends to be suboptimal (6,24), 
whereas other studies found that patients with dementia 
receive the same procedures and good care of those without 
such diagnosis (7). The assumption of an underestimation 
of comorbidities in patients with dementia is unlikely to be 
real in an acute hospital setting, where regular diagnostic 
procedures are offered to all admitted patients, especially in 
internal medicine and geriatric wards. Our hypothesis is that 
the interaction with the acute hospital environment may be 
particularly challenging for people with cognitive impair-
ment. It is possible that persons with dementia have more 
difficulties to cope with the acute stressors related to hospi-
talization compared with those without such diagnosis. The 
high frequency of adverse clinical events found in the frame 
of this study in these patients is consistent with this hypoth-
esis. In our previous study (9), an additive effect was found 
for dementia and adverse events on in-hospital mortality. In 
this study, besides confirming the independent association of 
adverse events on mortality during hospital stay, this associa-
tion was also present at follow-up. Moreover, the presence of 
an association between adverse events and cognitive impair-
ment on mortality was established; in fact, the effect of 
impaired cognition on mortality was significant and strong 
only in patients who had at least one adverse event during 
hospital stay. One of the collected adverse events was delir-
ium, a frequent occurrence in acutely hospitalized patients 
with cognitive impairment. Delirium was recorded as an 
adverse event only if definitely not already present at admis-
sion; in fact, in this study, prevalence of delirium was much 
lower than in others (10). This decision was adopted in order 
to avoid an overlap between cognitive impairment diagno-
sis established with the SBT and delirium already present 
at admission and captured by some items of the same scale.
Cognitive impairment and functional decline are often asso-
ciated in geriatric patients, and, in the majority of cases, disa-
bility is a consequence of cognitive impairment. Nevertheless, 
in this study, cognitive impairment was still independently 
associated with in-hospital mortality after the inclusion in the 
analysis of functional status. On the other hand, functional 
disability was strongly associated with 3-month mortal-
ity annulling the effect of cognition. This finding could be 
explained by considering that disability may be a measure of 
severity of diseases other than cognitive impairment. Indeed, 
the analyses were adjusted for specific diseases, but not for 
the severity of each clinical conditions (information not avail-
able in the REPOSI registry), and disability has been already 
shown to be a good indicator of disease severity when evalu-
ating mortality in elderly people (25,26). This hypothesis 
underlines the fact that moderate and severe cognitive impair-
ment increase the risk of in-hospital mortality independently 
also from the severity of their comorbidities.
Major strengths of this REPOSI study are the multicentre 
design that involved 66 internal medicine and geriatric 
wards throughout Italy, resulting in a sample representative 
of the hospitalized elderly population in the country; and 
the inclusion of the patients during a period of 4 weeks 
(one per season), in order to balance the effect of seasons 
on acute diseases leading to hospitalization. However, a 
few limitations need to be mentioned. First, problems can 
arise by using hospital data for research purposes because 
hospital records are not designed for research purposes but 
rather for patient care, and their diagnostic quality may vary 
depending on different hospitals, physicians, and clinical 
units. Moreover, hospital admissions are often selective 
on the basis of ward characteristics, severity of disease, 
associated medical conditions, and admissions policies that 
may vary from hospital to hospital. Second, information 
after 3 months was collected by phone calls and, thus, we 
cannot completely rule out recall biases as well as missing 
data of people who died during the follow-up. Finally, 
cognitive impairment and dementia in medical in-patients 
can be missed by physicians (27), however, a simple 
screening tool such as the SBT used in this study may help 
to identify patients with cognitive impairment even if a 
diagnosis of dementia is not reported.
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In conclusion, these findings provide evidence that 
impaired cognition is an independent risk factor for mor-
tality during acute hospital stay. Moreover, there is a cor-
relation between the severity of cognitive impairment and 
mortality. Adverse clinical events during hospital stay may 
represent a target of prevention due to their high correlation 
with mortality and cognitive impairment.
Supplementary Material
Supplementary material can be found at: http://biomedgerontology.
oxfordjournals.org/
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